{"id":"https://openalex.org/W4416844585","doi":"https://doi.org/10.1158/1078-0432.30750585","title":"Supplementary Materials S1 from BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor\u2013Positive Breast Cancer via Induction of miR-34a-5p","display_name":"Supplementary Materials S1 from BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor\u2013Positive Breast Cancer via Induction of miR-34a-5p","publication_year":2025,"publication_date":"2025-12-01","ids":{"openalex":"https://openalex.org/W4416844585","doi":"https://doi.org/10.1158/1078-0432.30750585"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30750585","doi":"https://doi.org/10.1158/1078-0432.30750585","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750585","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_S1_from_BET_Bromodomain_Inhibition_Reverses_CDK4_6_Inhibitor_Resistance_in_Estrogen_Receptor_Positive_Breast_Cancer_via_Induction_of_miR-34a-5p/30750585/1/files/59994297.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_S1_from_BET_Bromodomain_Inhibition_Reverses_CDK4_6_Inhibitor_Resistance_in_Estrogen_Receptor_Positive_Breast_Cancer_via_Induction_of_miR-34a-5p/30750585/1/files/59994297.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102482457","display_name":"Renyan Liu","orcid":"https://orcid.org/0009-0009-5676-3350","observed_orcids":["https://orcid.org/0009-0009-5676-3350"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renyan Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5676-3350","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087528175","display_name":"Xin Wang","orcid":"https://orcid.org/0009-0007-9132-405X","observed_orcids":["https://orcid.org/0009-0007-9132-405X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-9132-405X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009370475","display_name":"Timothy B. Branigan","orcid":"https://orcid.org/0009-0000-7301-8445","observed_orcids":["https://orcid.org/0009-0000-7301-8445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy B. Branigan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-7301-8445","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015550698","display_name":"Daryl Griffin","orcid":"https://orcid.org/0000-0003-2444-9497","observed_orcids":["https://orcid.org/0000-0003-2444-9497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daryl Griffin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2444-9497","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109290246","display_name":"Caoibhne McSweeney","orcid":"https://orcid.org/0009-0006-4143-5213","observed_orcids":["https://orcid.org/0009-0006-4143-5213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caoibhne McSweeney","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-4143-5213","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017635065","display_name":"Jie Hao","orcid":"https://orcid.org/0000-0002-4610-0563","observed_orcids":["https://orcid.org/0000-0002-4610-0563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Hao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4610-0563","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034379066","display_name":"Constantia Pantelidou","orcid":"https://orcid.org/0000-0003-2750-9352","observed_orcids":["https://orcid.org/0000-0003-2750-9352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Constantia Pantelidou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2750-9352","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080768582","display_name":"Zachary T. Herbert","orcid":"https://orcid.org/0000-0001-9401-2464","observed_orcids":["https://orcid.org/0000-0001-9401-2464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary T. Herbert","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9401-2464","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039038038","display_name":"Heta Jadhav","orcid":"https://orcid.org/0009-0000-8291-3409","observed_orcids":["https://orcid.org/0009-0000-8291-3409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heta Jadhav","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-8291-3409","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey I. Shapiro","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3331-4095","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.7480000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.7480000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.19760000705718994,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.026100000366568565,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-bromodomain-inhibition","display_name":"BET bromodomain inhibition","score":0.925000011920929},{"id":"https://openalex.org/keywords/cdk4-6-inhibitor-resistance","display_name":"CDK4/6 inhibitor resistance","score":0.9909999966621399},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/mir-34a-5p","display_name":"miR-34a-5p","score":0.9929999709129333},{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.6269999742507935},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.7508999705314636},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6482999920845032},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5878999829292297},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.5667999982833862},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.492000013589859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4830999970436096},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39160001277923584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3783999979496002},{"id":"https://openalex.org/C2779889926","wikidata":"https://www.wikidata.org/wiki/Q425223","display_name":"Raloxifene","level":5,"score":0.35740000009536743},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.3294000029563904},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32600000500679016},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.3244999945163727},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.3037000000476837},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.2937000095844269},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.26030001044273376}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30750585","doi":"https://doi.org/10.1158/1078-0432.30750585","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750585","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_S1_from_BET_Bromodomain_Inhibition_Reverses_CDK4_6_Inhibitor_Resistance_in_Estrogen_Receptor_Positive_Breast_Cancer_via_Induction_of_miR-34a-5p/30750585/1/files/59994297.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30750585","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Materials_S1_from_BET_Bromodomain_Inhibition_Reverses_CDK4_6_Inhibitor_Resistance_in_Estrogen_Receptor_Positive_Breast_Cancer_via_Induction_of_miR-34a-5p/30750585","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30750585","doi":"https://doi.org/10.1158/1078-0432.30750585","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30750585","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Materials_S1_from_BET_Bromodomain_Inhibition_Reverses_CDK4_6_Inhibitor_Resistance_in_Estrogen_Receptor_Positive_Breast_Cancer_via_Induction_of_miR-34a-5p/30750585/1/files/59994297.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416844585.pdf","grobid_xml":"https://content.openalex.org/works/W4416844585.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414908280","https://openalex.org/W4416852238","https://openalex.org/W4282967990","https://openalex.org/W3082493030","https://openalex.org/W7127053567","https://openalex.org/W2918928681","https://openalex.org/W6920376556","https://openalex.org/W6920721606","https://openalex.org/W3212605524","https://openalex.org/W3049629381"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-12-01T00:00:00"}